Q3: How should 5-Amino-1MQ Peptide Therapy be taken for best results
When used appropriately under physician guidance as part of comprehensive metabolic optimization strategies, AOD-9604 may provide a research-based tool for individuals committed to evidence-informed approaches to body composition improvement
Nicotinamide-N-methyltransferase controls behavior, neurodegeneration and lifespan by regulating neuronal autophagy
Our team is here to help you
What the FDA Label Says (There Isn't One) AOD-9604 has no FDA-approved prescribing label
Mechanism of Action 5-Amino-1MQ exerts its metabolic effects primarily through competitive inhibition of nicotinamide N-methyltransferase (NNMT), an enzyme belonging to the methyltransferase superfamily that is expressed in multiple tissues including liver, adipose tissue, skeletal muscle, kidney, and brain, with particularly high expression in visceral (abdominal) adipose tissue - the fat depot most strongly associated with metabolic disease